Skip to content

The effect of positive psychotherapy on gastrointestinal cancer

The Comparison of positive psychotherapy via virtual reality and face-to-face methods on the intensity of pain, anxiety, depression and hope of patients with gastrointestinal cancer hospitalized in Hospital

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250506065617N1
Enrollment
105
Registered
2025-07-26
Start date
2025-06-22
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cancer. Malignant neoplasm of ill-defined sites within the digestive system

Interventions

Intervention 1: Intervention Group 1: Participants in this group will receive three sessions of positive psychotherapy delivered via virtual reality technology. The intervention content consists of ed

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Willingness to participate in the study The patient's mental and physical readiness and suitability to participate in the study Diagnosis of gastrointestinal cancer based on the information available in the patient's medical records Ability to actively participate in the treatment process (no visual impairment, no hearing problems, adequate speech ability, and literacy in reading and writing)

Exclusion criteria

Exclusion criteria: Presence of severe and active psychiatric disorders such as schizophrenia, uncontrolled bipolar disorder, or acute psychosis. History of psychiatric hospitalization within the past six months or regular use of antipsychotic medications. Presence of moderate to severe cognitive impairments (such as dementia or intellectual disability) that interfere with understanding the content of therapy. History of active seizures or uncontrolled epilepsy (especially in patients assigned to the virtual reality intervention group). Concurrent participation in other psychotherapeutic or psychological interventions during the study period.

Design outcomes

Primary

MeasureTime frame
Hope. Timepoint: Before and after each intervention session (a total of 6 times during 3 intervention sessions on days 1, 3 and 5). Method of measurement: Snyder Hope Questionnaire.

Secondary

MeasureTime frame
Intensity of pain. Timepoint: Before and after each intervention session (a total of 6 times during 3 intervention sessions on days 1, 3 and 5). Method of measurement: Numeric Rating Scale.;Anxiety. Timepoint: Before and after each intervention session (a total of 6 times during 3 intervention sessions on days 1, 3 and 5). Method of measurement: Hospital Anxiety and Depression Scale.;Depression. Timepoint: Before and after each intervention session (a total of 6 times during 3 intervention sessions on days 1, 3 and 5). Method of measurement: Hospital Anxiety and Depression Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Maryam Shaygan

Shiraz University of Medical Sciences

m2620.shaygan@gmail.com+98 71 3647 4254

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026